|Articles|October 25, 2011

Medical Economics Digital Edition - 10/25/2011

Road to Meaningful Use

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Medical Economics

When a device maker goes dark: What the Boston Scientific cyberattack means for your patients

Dolly Parton's health care legacy: Two decades of giving

Employer health care costs brace for a volatile 2027

Amazon Health AI’s digital front door may close the door on independent primary care

Nearly 1 in 4 NFL players had CTE at death; first U.S. measles deaths of 2026 reported in Pennsylvania; Dolly Parton's health care legacy — Morning Medical Update Weekly Recap